Alphatec Spine to Host Technology Day on June 6, 2013 in New York City

Alphatec Spine to Host Technology Day on June 6, 2013 in New York City

Venue: Convene Conference Center (730 Third Avenue) From 8:30 AM to 11:30 AM

CARLSBAD, Calif., May 9, 2013 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc.
(Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device
company that designs, develops, manufactures and markets physician-inspired
solutions for patients with spinal disorders, announced today that the Company
will conduct a Technology Day for investors and analysts on Thursday, June 6,
2013 from 8:30 AM to 11:30 AM Eastern Time at the Convene Conference Center
(formerly Sentry Centers), which is located at 730 Third Avenue in NYC.

The agenda will include presentations from Alphatec's senior management and
select spine surgeons, followed by a question and answer period and product
demonstrations. To register for this event, please RSVP to investor relations
prior to May 31, 2013. Seating is limited.

"We are extremely pleased to showcase our newest products including our
Alphatec Solus® anchored, anterior lumbar interbody fusion device, our
Pegasus™ anchored, anterior cervical interbody device, our new Zodiac® DVR
(Direct Vertebral Rotation) System, and our expanding portfolio of ILLICO®
minimally invasive surgery systems (MIS), including our ILLICO Multi-Level MIS
System," said Les Cross, Chairman and CEO of Alphatec Spine. "We invite
members of the financial community to attend our event and learn more about
Alphatec Spine's innovations in the spine industry that are helping to improve
patient care in the operating room."

The presentations made by the Company's management at the Alphatec Spine
Technology Day will be webcast live and accessible through the Company's
investor relations website at www.alphatecspine.com. An archived edition of
the presentation will be available later that day and will be available for at
least 30 days afterwards.

About Alphatec Spine

Alphatec Spine, Inc., a wholly owned subsidiary of Alphatec Holdings, Inc., is
a medical device company that designs, develops, manufactures and markets
products and solutions for the treatment of spinal disorders associated with
trauma, congenital deformities, disease and degeneration. The Company's
mission is to combine innovative, surgeon-inspired solutions that will help
improve outcomes and patient's quality of life, with world-class customer
service. To achieve its mission, the Company strives to commercialize new and
innovative devices and technologies, including improved minimally invasive
surgery (MIS) products and techniques and integrated biologics solutions. The
Company markets its products and the products of its affiliates in the U.S.
and in over 50 countries internationally via a direct sales force and
independent distributors. Additional information can be found at
www.alphatecspine.com.

Forward Looking Statements

This press release may contain "forward-looking statements" within the meaning
of the Private Securities Litigation Reform Act of 1995 that involve risks and
uncertainty. Such statements are based on management's current expectations
and are subject to a number of risks and uncertainties that could cause actual
results to differ materially from those described in the forward-looking
statements. Alphatec Spine cautions investors that there can be no assurance
that actual results or business conditions will not differ materially from
those projected or suggested in such forward-looking statements as a result of
various factors. Forward looking statements include references to the
Company's commercial strategy for its products, including those products noted
in this release. The words "believe," "will," "should," "expect," "intend,"
"estimate" and "anticipate," variations of such words and similar expressions
identify forward-looking statements, but their absence does not mean that a
statement is not a forward-looking statement. The important factors that
could cause actual operating results to differ significantly from those
expressed or implied by such forward-looking statements include, but are not
limited to; the uncertainty of the commercial success of the Alphatec Solus,
Pegasus, ILLICO and Zodiac DVR systems ; the uncertainty of success in
licensing or developing and commercializing new products or products currently
in Alphatec Spine's pipeline; failure to achieve acceptance of Alphatec
Spine's products by the surgeon community, including the Alphatec Solus,
Pegasus, ILLICO and Zodiac DVR systems ; failure to successfully implement
streamlining activities to create anticipated operational savings; failure to
successfully begin in-house manufacturing of certain products; failure to
obtain FDA clearance or approval for new products, , or unexpected or
prolonged delays in the process; Alphatec Spine's ability to develop and
expand its U.S. and/or global revenues; continuation of favorable third party
payor reimbursement for procedures performed using Alphatec Spine's products;
unanticipated expenses or liabilities or other adverse events affecting cash
flow or Alphatec Spine's ability to successfully control its costs or achieve
profitability; uncertainty of additional funding; Alphatec Spine's ability to
compete with other competing products and with emerging new technologies;
product liability exposure; failure to meet all financial obligations in the
Cross Medical Settlement or its credit agreement; patent infringement claims
and claims related to Alphatec Spine's intellectual property or products sold
by Alphatec Spine. Please refer to the risks detailed from time to time in
Alphatec Spine's SEC reports, including its Annual Report Form 10-K for the
year ended December 31, 2012, filed on March 5, 2013 with the Securities and
Exchange Commission, as well as other filings on Form 10-Q and periodic
filings on Form 8-K. Alphatec Spine disclaims any intention or obligation to
update or revise any forward-looking statements, whether as a result of new
information, future events, or otherwise, unless required by law.

CONTACT: Investor/Media Contact:
        
         Mark Francois
         Senior Director, Investor Relations
         Alphatec Spine, Inc.
         (760) 494-6610
         mfrancois@AlphatecSpine.com

Alphatec Spine